Kaštelan, S.; Konjevoda, S.; Sarić, A.; Urlić, I.; Lovrić, I.; Čanović, S.; Matejić, T.; Šešelja Perišin, A.
Resveratrol as a Novel Therapeutic Approach for Diabetic Retinopathy: Molecular Mechanisms, Clinical Potential, and Future Challenges. Molecules 2025, 30, 3262.
https://doi.org/10.3390/molecules30153262
AMA Style
Kaštelan S, Konjevoda S, Sarić A, Urlić I, Lovrić I, Čanović S, Matejić T, Šešelja Perišin A.
Resveratrol as a Novel Therapeutic Approach for Diabetic Retinopathy: Molecular Mechanisms, Clinical Potential, and Future Challenges. Molecules. 2025; 30(15):3262.
https://doi.org/10.3390/molecules30153262
Chicago/Turabian Style
Kaštelan, Snježana, Suzana Konjevoda, Ana Sarić, Iris Urlić, Ivana Lovrić, Samir Čanović, Tomislav Matejić, and Ana Šešelja Perišin.
2025. "Resveratrol as a Novel Therapeutic Approach for Diabetic Retinopathy: Molecular Mechanisms, Clinical Potential, and Future Challenges" Molecules 30, no. 15: 3262.
https://doi.org/10.3390/molecules30153262
APA Style
Kaštelan, S., Konjevoda, S., Sarić, A., Urlić, I., Lovrić, I., Čanović, S., Matejić, T., & Šešelja Perišin, A.
(2025). Resveratrol as a Novel Therapeutic Approach for Diabetic Retinopathy: Molecular Mechanisms, Clinical Potential, and Future Challenges. Molecules, 30(15), 3262.
https://doi.org/10.3390/molecules30153262